• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.新型冠状病毒肺炎与银屑病：是时候限制免疫抑制剂的使用了吗？呼吁采取行动。
Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22.
2
Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action".关于《COVID-19与银屑病：是时候限制免疫抑制剂治疗了吗？行动呼吁》的评论
Dermatol Ther. 2020 Jul;33(4):e13360. doi: 10.1111/dth.13360. Epub 2020 Apr 16.
3
Should biologics for psoriasis be interrupted in the era of COVID-19?在新冠疫情时代，银屑病生物制剂是否应中断使用？
J Am Acad Dermatol. 2020 May;82(5):1217-1218. doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19.
4
COVID-19 and psoriasis: Should we fear for patients treated with biologics?COVID-19 与银屑病：接受生物制剂治疗的患者是否需要担心？
Dermatol Ther. 2020 Jul;33(4):e13434. doi: 10.1111/dth.13434. Epub 2020 May 5.
5
Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID-19 days.银屑病和银屑病关节炎：在新冠疫情期间如何管理免疫抑制剂
Dermatol Ther. 2020 Jul;33(4):e13415. doi: 10.1111/dth.13415. Epub 2020 May 2.
6
Guttate psoriasis secondary to COVID-19.新型冠状病毒肺炎继发点滴状银屑病。
BMJ Case Rep. 2020 Aug 11;13(8):e237367. doi: 10.1136/bcr-2020-237367.
7
COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.患有少突胶质细胞瘤的红皮病型银屑病患者的COVID-19肺部感染：阿普米司特与重症监护管理的安全性和兼容性
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e376-e378. doi: 10.1111/jdv.16625. Epub 2020 Jun 4.
8
Anticoagulants and immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS.新冠疫情中的抗凝剂和免疫抑制剂：对抗微小血栓的利器
Ann Card Anaesth. 2020 Jul-Sep;23(3):258-259. doi: 10.4103/aca.ACA_126_20.
9
Cancer and COVID-19: A call for comments.癌症与2019冠状病毒病：征求意见
Psychooncology. 2020 Apr;29(4):803. doi: 10.1002/pon.5384.
10
Should patients stop their biologic treatment during the COVID-19 pandemic.在新冠疫情期间，患者是否应该停止生物制剂治疗？
J Dermatolog Treat. 2020 Jun;31(4):317-318. doi: 10.1080/09546634.2020.1742438. Epub 2020 Mar 19.

引用本文的文献

1
Post-COVID pigment loss: the connection between vitiligo and the pandemic.新冠后色素脱失：白癜风与大流行之间的联系
Postepy Dermatol Alergol. 2024 Apr;41(2):197-202. doi: 10.5114/ada.2024.138670. Epub 2024 Apr 9.
2
Biologic Therapies Decrease Disease Severity and Improve Depression and Anxiety Symptoms in Psoriasis Patients.生物疗法可降低银屑病患者的疾病严重程度，并改善其抑郁和焦虑症状。
Life (Basel). 2023 May 19;13(5):1219. doi: 10.3390/life13051219.
3
Psoriasis flares after COVID-19 vaccination: adherence to biologic therapy reduces psoriasis exacerbations: a case-control study.新冠病毒疫苗接种后银屑病发作：坚持生物治疗可减少银屑病加重：一项病例对照研究。
Clin Exp Vaccine Res. 2023 Jan;12(1):80-81. doi: 10.7774/cevr.2023.12.1.80. Epub 2023 Jan 31.
4
The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review.2019年冠状病毒病大流行对皮肤病的影响：一项新颖的全面综述
Dermatopathology (Basel). 2022 Jun 29;9(3):212-243. doi: 10.3390/dermatopathology9030027.
5
Research on Quantitative Analysis of Multiple Factors Affecting COVID-19 Spread.影响新型冠状病毒肺炎传播的多因素定量分析研究
Int J Environ Res Public Health. 2022 Mar 8;19(6):3187. doi: 10.3390/ijerph19063187.
6
Perception of the threat, mental health burden, and healthcare-seeking behavior change among psoriasis patients during the COVID-19 pandemic.COVID-19 大流行期间银屑病患者对威胁的感知、心理健康负担和就医行为的改变。
PLoS One. 2021 Dec 9;16(12):e0259852. doi: 10.1371/journal.pone.0259852. eCollection 2021.
7
COVID-19 and Dermatology in Iran.新型冠状病毒肺炎（COVID-19）与伊朗的皮肤病学
Clin Dermatol. 2021 Jul-Aug;39(4):703-706. doi: 10.1016/j.clindermatol.2021.05.022. Epub 2021 May 18.
8
Letter to the editor regarding article "Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1-5".致编辑的信：关于文章“Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. 新冠疫情早期生物制剂治疗银屑病：一项关于患者对治疗及疾病进程态度的研究。《美容皮肤科杂志》。2021年；00:1 - 5”
J Cosmet Dermatol. 2021 Dec;20(12):4073-4075. doi: 10.1111/jocd.14550. Epub 2021 Oct 28.
9
Changes in Dietary Patterns and Clinical Health Outcomes in Different Countries during the SARS-CoV-2 Pandemic.在 SARS-CoV-2 大流行期间不同国家饮食模式的变化与临床健康结果。
Nutrients. 2021 Oct 15;13(10):3612. doi: 10.3390/nu13103612.
10
Influence of SARS-CoV-2 Virus Infection on the Course of Psoriasis during Treatment with Biological Drugs.新型冠状病毒感染对生物制剂治疗银屑病过程中疾病的影响。
Medicina (Kaunas). 2021 Aug 27;57(9):881. doi: 10.3390/medicina57090881.

本文引用的文献

1
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
2
Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis.银屑病的口服环孢素：治疗方式、肾毒性风险的系统评价及非斑块型银屑病应用证据。
J Eur Acad Dermatol Venereol. 2011 May;25 Suppl 2:19-27. doi: 10.1111/j.1468-3083.2011.03992.x.
3
Anti-tumor necrosis factor therapy and influenza: keeping it in perspective.抗肿瘤坏死因子治疗与流感：客观看待。
Therap Adv Gastroenterol. 2010 May;3(3):173-7. doi: 10.1177/1756283X10366368.
4
Fatal influenza A(H1N1) respiratory tract infection in a patient having psoriasis treated with infliximab.一名接受英夫利昔单抗治疗的银屑病患者发生致命性甲型H1N1流感呼吸道感染。
Arch Dermatol. 2010 Jun;146(6):651-4. doi: 10.1001/archdermatol.2010.96.
5
Influenza H1N1 infection in a patient with psoriatic arthritis in treatment with Adalimumab: a case report.阿达木单抗治疗中银屑病关节炎患者感染甲型 H1N1 流感：1 例报告。
Clin Rheumatol. 2013 Mar;32 Suppl 1(Suppl 1):S21-3. doi: 10.1007/s10067-010-1415-5. Epub 2010 Mar 5.

COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.

作者信息

Conforti Claudio, Giuffrida Roberta, Dianzani Caterina, Di Meo Nicola, Zalaudek Iris

机构信息

Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy.

Department of Clinical and Experimental Medicine, Dermatology, University of Messina, Messina, Italy.

出版信息

Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22.

DOI:10.1111/dth.13298
PMID:32157783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7228204/
Abstract
摘要